Astrana Health Stock Price, News & Analysis

Astrana Health (NASDAQ: ASTH) announced it will release its Q3 2024 financial results on Thursday, November 7, 2024, after market close. The company will host a conference call at 2:30 p.m. PT/5:30 p.m. ET on the same day to discuss the results. Participants can join via phone at (888) 272-8703 or +1 713-481-1320. A slide presentation will be available on the company's IR website, and the call will be accessible through a webcast with recording available afterward.

Astrana Health, Inc. (NASDAQ: ASTH) has completed its acquisition of Collaborative Health Systems (CHS), previously a Centene (NYSE:CNC) company. This strategic move expands Astrana's provider network and value-based care capabilities across 17 states, serving over 129,000 beneficiaries. The acquisition aims to:

1. Enhance payer-agnostic care delivery across all business lines
2. Integrate complementary provider footprints in key markets
3. Leverage Astrana's Care Enablement platform to improve patient outcomes

Brandon Sim, CEO of Astrana Health, emphasized that this acquisition will strengthen the company's position in delivering high-quality, accessible healthcare. The transaction has received necessary regulatory approvals, with updated financial outlooks to be provided in Astrana's Q3 2024 earnings call.

Astrana Health (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company, has announced its participation in four upcoming investor conferences in September 2024. These include:

• The Wells Fargo Healthcare Conference in Boston on September 4
• The Morgan Stanley 22nd Annual Global Healthcare Conference in New York on September 6, featuring a fireside chat at 12:20pm ET
• The Cowen 9th Annual FutureHealth Conference in New York on September 10, including a panel discussion at 1:25pm ET
• The Baird Global Healthcare Conference in New York on September 11, with a fireside chat at 2:00pm ET

This series of conference appearances demonstrates Astrana's commitment to engaging with investors and showcasing its role in delivering accessible, high-quality, and high-value healthcare.

Astrana Health (NASDAQ: ASTH) reported strong Q2 2024 results, with total revenue up 40% to $486.3 million and net income up 46% to $19.2 million. The company's Care Partners segment drove growth, with revenue increasing 44% to $463.3 million. Adjusted EBITDA rose 34% to $47.9 million. Astrana expanded into Arizona and Hawaii, partnered with Anthem Blue Cross and Elation Health, and agreed to acquire Collaborative Health Systems. The company updated its 2024 guidance, projecting total revenue between $1.75-$1.85 billion and net income of $54-$66 million. CEO Brandon K. Sim highlighted the company's progress in delivering value-based care across communities.

Astrana Health (NASDAQ: ASTH) has announced a definitive agreement to acquire Collaborative Health Systems (CHS), a management services organization serving over 129,000 beneficiaries across 17 states and a company of Centene (NYSE:CNC). This acquisition aims to expand Astrana's payer-agnostic care delivery capabilities and empower CHS' providers. The deal combines Astrana's technology platform and care model with CHS's provider base and payer partnerships, potentially accelerating Astrana's goal of organizing providers and enhancing patient healthcare experiences.

CHS has a complementary provider footprint in key markets including Connecticut, Georgia, Maryland, New Mexico, Virginia, and Texas. Astrana plans to leverage its Care Enablement platform to improve patient outcomes. The transaction is expected to close by year-end, subject to regulatory approvals. Financial details will be updated post-closure, with more information to be discussed during Astrana's August 7 quarterly earnings presentation.

Astrana Health, Inc. (NASDAQ: ASTH) has announced the schedule for its 2024 Second Quarter Financial Results release and conference call. The company, a leading provider-centric, technology-powered healthcare organization, will release its financial results for the quarter ended June 30, 2024, after the stock market closes on Wednesday, August 7, 2024. A conference call to discuss these results is scheduled for 2:30 p.m. PT/5:30 p.m. ET on the same day.

Participants can join the call using the dial-in numbers (888) 437-3179 or (862) 298-0702. An accompanying slide presentation will be available on the company's website. For those unable to attend the live call, a webcast will be accessible at the provided link, with a recording available shortly after the call concludes.

Astrana Health (NASDAQ: ASTH) and Elation Health have formed a strategic partnership to empower primary care providers in value-based care. The collaboration aims to scale risk-bearing entities, including accountable care organizations and clinically integrated networks. Elation will provide its EHR platform, practice transformation, and billing technology, while Astrana will deploy its value-based care platform and enablement solutions.

As a first example, Astrana will support an existing provider organization in Hawai'i, working with over 100 primary care providers serving 20,000+ primarily Medicare patients. Providers are expected to onboard into Astrana's Care Enablement platform by the end of Q3 2024. This partnership aims to integrate Elation's EHR technology with Astrana's value-based care infrastructure to enhance member experience, improve outcomes, and lower costs.

Astrana Health (NASDAQ: ASTH) and Anthem Blue Cross have announced a strategic partnership to enhance healthcare access and quality for their shared members. This collaboration aims to address social and health inequities in underserved communities. As part of the initiative, Astrana will open and manage clinics exclusively for Anthem Blue Cross and Allied Pacific IPA members, offering walk-in visits, telemedicine, and online scheduling.

The partnership's first collaborative care clinic has opened in Whittier, California, serving Anthem Blue Cross and Allied Pacific IPA members with HMO plans. The facility focuses on comprehensive health assessments, preventive care, and chronic disease management. This partnership represents both organizations' commitment to improving healthcare accessibility and quality in previously underserved areas.

Astrana Health, a healthcare technology company listed on NASDAQ as ASTH, announced its participation in three upcoming investor conferences. The Leerink Healthcare Crossroads Conference will take place in Austin on May 29, 2024, featuring a fireside chat at 1:00pm CT. The William Blair 44th Annual Growth Stock Conference will occur in Chicago on June 5, 2024, with a presentation at 4:40pm CT. Lastly, the Truist Healthcare Disruptors & Digital Health Summit will be held in New York on June 25, 2024, including a panel presentation at 3:30pm ET. Webcast links for these events will be available on Astrana Health's investor relations website.